Product Overview
COLOREX™ VRE is a selective and differential chromogenic medium, containing 6 mg/L of vancomycin, intended for use in the qualitative direct detection of vanA/vanB transmissible VRE-type gastrointestinal colonization with vancomycin-resistant Enterococcus faecium and Enterococcus faecalis (VRE) to aid in the prevention and control of VRE in healthcare settings. The test is performed with rectal swab and stools from patients to screen for VRE colonization. Results can be interpreted after 24 h of aerobic incubation at 35-37 °C.
The medium can also be used as an early warning indicator for diagnostic tests of infections to signal the possible presence of multi drug-resistant bacteria. This use does not replace the institution’s protocols. COLOREX™ VRE is not intended to diagnose VRE infection nor to guide nor monitor treatment for infections. A lack of growth or the absence of pink colonies on COLOREX™ VRE does not preclude the presence of VRE. Further identification, susceptibility testing, and epidemiological typing is needed on suspect colonies.
